🇺🇸 Tacalcitol ointment in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Adrenal Suppression — 1 report (10%)
- Blood Corticotrophin Decreased — 1 report (10%)
- C-Reactive Protein Increased — 1 report (10%)
- Cushing'S Syndrome — 1 report (10%)
- Diabetes Mellitus Insulin-Dependent — 1 report (10%)
- Drug Ineffective — 1 report (10%)
- General Physical Health Deterioration — 1 report (10%)
- Hypertension — 1 report (10%)
- Leukocytosis — 1 report (10%)
- Psoriasis — 1 report (10%)
Other Dermatology approved in United States
Frequently asked questions
Is Tacalcitol ointment approved in United States?
Tacalcitol ointment does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Tacalcitol ointment in United States?
LEO Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.